Indian FDA pushes for broader generic-drug use

04/21/2013 | Times of India, The

A state Food and Drug Administration commissioner in India denied that the bio-availability of generic drugs is doubtful, in spite of claims to the contrary made by doctors and chemists. "Bio-availability" is a term used for the amount of a drug that reaches its target. "These are excuses to deny people their right to get medicines at rational prices," said Commissioner Mahesh Zagade, who urged the national government to require that physicians add a line to prescriptions noting that generic or other cheaper versions are available.

View Full Article in:

Times of India, The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Consumer Directed Health Plan (CDH) Product Offering Manager
Blue Cross Blue Shield MA
Quincy, MA
ISHN - Chief Compliance Officer
Mountain States Health Alliance
Johnson City, TN
Actuary
Meridian Health Plan
Detroit, MI
President/Chief Executive Officer
MedCost
Winston-Salem, NC
Director, Payer Marketing
Avalere Health
Washington, DC